Gemcitabine Interactions
There are 283 drugs known to interact with gemcitabine, along with 10 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 55 are major, 210 are moderate, and 18 are minor.
- View all 283 medications that may interact with gemcitabine
- View gemcitabine alcohol/food interactions (1)
- View gemcitabine disease interactions (10)
Most frequently checked interactions
View interaction reports for gemcitabine and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Ambien (zolpidem)
- Aspirin Low Strength (aspirin)
- Ativan (lorazepam)
- Augmentin (amoxicillin / clavulanate)
- Benadryl (diphenhydramine)
- Celebrex (celecoxib)
- Cipro (ciprofloxacin)
- Claritin (loratadine)
- Compazine (prochlorperazine)
- CoQ10 (ubiquinone)
- Creon (pancrelipase)
- Dilaudid (hydromorphone)
- Eliquis (apixaban)
- Fentanyl Transdermal System (fentanyl)
- Herceptin (trastuzumab)
- Lovenox (enoxaparin)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Morphine Sulfate ER (morphine)
- Neulasta (pegfilgrastim)
- Neupogen (filgrastim)
- Protonix (pantoprazole)
- Spiriva (tiotropium)
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
Gemcitabine alcohol/food interactions
There is 1 alcohol/food interaction with gemcitabine.
Gemcitabine disease interactions
There are 10 disease interactions with gemcitabine which include:
- infections
- cardiovascular dysfunction
- hemolytic uremic syndrome
- myelosuppression
- cerebrovascular disease
- edema
- hepatic dysfunction
- paresthesia
- pulmonary dysfunction
- renal dysfunction
Report options
More about gemcitabine
- gemcitabine consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (9)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antimetabolites
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Loqtorzi
Loqtorzi (toripalimab-tpzi) is a PD-1 inhibitor medicine used for the treatment of advanced ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.